CD8A and neoplasm: V domain immunoglobulin suppressor of T cell activation (VISTA), a B7 family immune checkpoint protein expressed on T cells, drives T cell inhibition by binding to homologous ligands [211], it has been proven in tumor models that VISTA blockade can enhance the proliferation and cytotoxic function of CD8+ Teff [212].